IBM Just Had Its Worst Day Ever—What Earnings Must Prove

IBM shares fell more than 25% after the company pre-reported weaker-than-expected Q2 2026 revenue and earnings ahead of its official July 22 report. IBM faces a securities-fraud inquiry into whether it exaggerated its sales pipeline before the preannouncement, raising questions about its forecasting credibility. Investors will also watch for progress on IBM's quantum computing roadmap and reassurance that cash flow can sustain its 30-year dividend growth streak.

IBM NYSE: IBM pre-reported its Q2 2026 earnings on July 14, and investors punished the stock, sending it down over 25% in a single session—the worst one-day decline in the company’s storied history. At a time when there are many concerns about the valuation of technology stocks, bad news in any form will be punished.

But did the sell-off go too far? IBM will deliver its official earnings report on July 22. While the headline numbers shouldn't change from the preview, this will be a chance for Big Blue to provide forward guidance and add context for the disappointing revenue and earnings numbers. There may not be much that IBM can say on the conference call to reverse the immediate impact on its stock. Investors have already sent a clear message: they are not confident in IBM right now. But a look at the chart shows a stock that’s made sharp moves up and down in the last 12 months. IBM is a volatile trade, to be sure, but is it a poor investment?

IBM said that Q2 revenue would be $17.2 billion, which is below analyst expectations of $17.9 billion, but up about 1% from the $16.98 billion that IBM reported in Q2 2025. That growth is far below the year-over-year gains the company has posted in the three prior quarters. A similar pattern was seen in the company’s adjusted earnings per share (EPS), which IBM says will be $2.93. That’s below estimates of $3.01 and only a slight beat of the $2.80 it recorded in Q2 2025. As for why, management said that many of its customers reprioritized their capital spending in June, locking in prices on servers, storage, and memory before anticipated price increases. That makes sense in an AI infrastructure trade that has seen money flow from one sector to another and back again. But what comes now? The company needs to answer three questions when it reports official earnings on July 22 to begin rebuilding investor confidence.

1. Did IBM Overstate Its Sales Pipeline Before Earnings? IBM is facing a securities-fraud inquiry into whether it exaggerated its sales pipeline ahead of the July 14 preannouncement. These preliminary inquiries do not establish wrongdoing, but they raise the stakes for the upcoming conference call beyond a simple explanation that customer spending was delayed. If management can't show that the shortfall was truly a timing issue—deals pushed from Q2 into Q3—rather than deals that were never as solid as the pipeline suggested, the stock's problem may go beyond this quarter and raise questions about IBM's own forecasting. Investors will be listening for specific answers. How much of the missed revenue has since been recovered, and what is IBM doing to tighten its reporting of pipeline strength going forward?

2. Can IBM's Quantum Computing Business Drive Future Growth? Quantum computing is in its early stages, but IBM has been one of the early ...